Brain+ A/S (CPH:BRAINP)
Denmark · Delayed Price · Currency is DKK 0.0100
+0.0004 (4.17%)
Dec 30, 2025, 4:18 PM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 11.33 million as of December 31, 2025. Its market cap has decreased by -45.16% in one year.
Market Cap
11.33M
Enterprise Value
6.99M
Revenue
5.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 11.33M, a decrease of -78.21%. That is a compound annual growth rate of -30.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 11.33M | -43.17% |
| Dec 30, 2024 | 19.94M | 56.98% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
| Oct 7, 2021 | 51.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.46T |
| Genmab | 130.78B |
| Coloplast | 122.33B |
| ALK-Abelló | 50.52B |
| Demant | 45.59B |
| H. Lundbeck | 41.13B |
| Zealand Pharma | 33.95B |
| Ambu A/S | 23.36B |